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ABSTRACT: The rise of three-dimensional cell culture
systems that provide in vivo-like environments for pharma-
co-toxicological models has prompted the need for simple and
robust viability assays suitable for complex cell architectural
structures. This study addresses that challenge with the
development of an in vitro enzyme based electrochemical
sensor for viability/cytotoxicity assessment of two-dimen-
sional (2D) monolayer and three-dimensional (3D) spheroid
culture formats. The biosensor measures the cell viability/
toxicity via electrochemical monitoring of the enzymatic
activity of nonspecific esterases of viable cells, through the
hydrolysis of 1-naphthyl acetate to 1-naphthol. The proposed
sensor demonstrated strong correlation (r = 0.979) with viable cell numbers. Furthermore, the model intestinal toxicants
diclofenac (DFC, pharmaceutical), okadaic acid (OA, food-safety), and mancozeb (MZB, environmental) were used for the
functional evaluation of the proposed sensor using 2D and 3D culture formats. Sensor performance showed high consistency
with conventional cell viability/cytotoxicity assays (MTT/CFDA-AM) for all toxicants, with the sensor IC50 values matching
the relevant viability LC50 values at the 95% confidence interval range for 2D (DCF: 1.19−1.26 mM, MZB: 10.28−14.18 μM,
OA: 40.91−77.13 nM) and 3D culture formats (DCF: 1.02−4.78 mM, MZB: 11.26−15.16 μM, OA: 162.09−179.67 nM). The
presented results demonstrate the feasibility of the proposed sensor as a robust endpoint screening tool for both 2D and 3D
cytotoxicity assessment.
KEYWORDS: spheroid-3D, electrochemical biosensor, screen-printed electrode, cytotoxicity, viability, nonspecific esterase,
substrate and enzymatic product
The adoption of effective and reliable human-derived invitro models that will replace animal-based studies is
becoming a necessity in the fields of drug screening, food
safety, and environmental risk assessment. Conventional
toxicological studies rely principally on the use of live animals
to analyze the efficacy and toxicity of drug candidates,
environmental agents, or food toxicants.1 However, the use
of animals has been debated as ethically provoking,2 cost-
ineffective, time-consuming, and low-throughput.3 Guiding
principles such as the “3Rs”, defined as Refinement, Reduction,
and Replacement, have contributed to the quest for
alternatives to the use of animals,4 increasing the need for
appropriate in vitro systems for toxicity assessment.
Cell-based platforms that can provide in vivo-relevant
biological information have proven to be valuable tools for
testing various physiological processes and are widely
employed as rapid, inexpensive, high throughput, miniaturized,
and automated screening substitutes.5,6 Cell based assays are
still predominantly dominated by conventional two-dimen-
sional (2D) monolayer cultures, where cells are grown in flat
layers on rigid materials such as polystyrene or glass surfaces.
These long-established cell monolayer cultures, however, do
not fully reflect the physiological properties of real tissues and
are increasingly recognized as inadequate formats for
predicting in vivo behavior.7,8
Over the past decades, there is a growing amount of research
suggesting that cells grown in three-dimensional (3D)
environments simulate more effectively the in vivo cellular
behavior of their native tissues, compared to cells grown in
classical 2D culture flasks.9 Three-dimensional structures
demonstrate tissue specific architecture, enhanced cell−cell
and cell−extracellular matrix interactions, resulting to tissue-
like functionality and in vivo-depictive responses to external
stimuli.10,11 3D culture models include organotypic explant
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cultures such as cell spheroids, microcarrier cultures, and
tissue-engineered models.12 Multicellular spheroids (MCS) are
aggregates of cells, in close contact with each other, which
without artificial substrate for cell attachment obtain a
symmetric, sphere-shaped form, analogous to tissues.13,14
MCS exhibit a characteristic in vivo-like morphology and
cellular environment15 and have been broadly used in 3D
culture methods for tumor models,16 hepatic17,18 and gastro-
intestinal19,20 culture systems, tissue engineering,21 and stem
cell biology research.22
The measurement of cell viability has an indispensable role
in all forms of cell culture and is the principal response
measured by cell-based assays for assessing the effect of
experimental treatments.23 The most commonly used methods
to estimate the number of viable eukaryotic cells involve the
use of microplate readers, flow cytometers, or high content
imaging. The majority of viability methodologies measure
some aspect of general metabolism or enzymatic activity, as a
marker of viable cells.24 Enzyme activity-based viability
methods are usually based on the optical, fluoroscence, or
luminescence monitoring of substrate consumption or end-
product formation by enzymes such as esterases, oxido-
reductases, or proteases.25 Among those, esterases are
ubiquitous enzymes that hydrolyze aliphatic or aromatic esters,
often collectively referred to as “non-specific esterases” (NSE).
They are established as viability indicators with numerous
commercially available substrates (Calcein, FDA, and CFDA)
that, once hydrolyzed by nonspecific esterases, yield
fluorescent products. The signal of such probes is proportional
to cell viability, as esterase activity decreases in cells with poor
vitality.26
Despite the continuous research on new probes and stains
for improved assessment of cell viability, these assays still have
limitations due to their sensitivity to experimental conditions
often leading to false-positive or false-negative results.27−29
In vitro electrochemical detection methods of cell viability
have been emerging as powerful alternatives to most cell based
assays, often proclaimed as sensitive, accurate, fast, inexpensive,
and easy to use techniques.30,31 The global biosensors market
is projected to touch US$25.9 billion by 2022 from an
estimated US$16.9 billion in 2017, and the electrochemical
biosensors are the largest part of the global biosensors market
by technology with a 2017 value at US$12 billion.32 In these
sensors the biological events are directly converted to an
electrical signal, obliterating the need for complex instrumen-
tation and providing advantages in terms of cost, simplicity,
and portability.33
In the present work, an in vitro electrochemical sensor based
on intracellular esterase activity was established for intestinal
viability/cytotoxicity assessment, in both 2D and 3D cell
culture formats. Among the portals of entry for foreign
compounds into the human body, the gastrointestinal tract
contributes to the first-pass clearance of foodborne or
waterborne routes of exposure.34 The intestine is an important
target of chemical- and toxin-induced toxicity due to its high
exposure after oral administration. Considering that the
assessment of first-pass metabolism in humans, in particular,
the intestinal first-pass, is challenging due to technical and
ethical complexities of such studies,35 our aim was to develop
an electrochemical cell-based approach that could provide cell
type specific insight on the biological activity of pharmaco-
logical substances, food toxins and environmental pollutants.
For this purpose, we investigated whether sensing of the
enzymatic hydrolysis of 1-naphthyl acetate by nonspecific
esterases of intestinal cells can be used as a viability assay, by
electrochemically monitoring the end-product (1-naphthol) as
a figure of merit for cellular activity.
Furthermore, the nonsteroidal anti-inflammatory drug
(NSAID) diclofenac (DCF), the ethylene bisdithiocarbamate
fungicide mancozeb (MZB), and the diarrheic shellfish
poisoning toxin okadaic acid (OA), all known for their
intestinal toxicity,36−38 were used for the functional evaluation
of the proposed biosensor and its correlation with established
colorimetric and fluorometric cell viability assays. In recent
years, it has become progressively clear that, besides the
stomach, the small intestine is also a major target organ of
NSAID-associated toxicity.39 DCF has been reported to induce
intestinal injury in both humans and various experimental
animal models with typical clinical signs of intestinal toxicity
such as small intestinal ulceration, bleeding, and inflamma-
tion.36,40 OA, another agent with gastrointestinal symptoms, is
a polyether fatty acid produced mainly by some species of
marine algae, causing diarrheic poisoning in humans after
consumption of shellfish that have fed on marine phytoplank-
ton containing the diarrheic toxin.41 Based on bioaccumulation
studies, in OA poisoning the distribution of the toxin is more
pronounced in the intestinal tissue.42 Finally, MZB, a fungicide
that belongs to the ethylene bisdithiocarbamate group, has also
been reported as a gastrointestinal toxicant that exhibits loss of
viability in various intestinal epithelium cell lines.38,43 All three
xenobiotics were selected on the basis of their reported
intestinal toxicity and on the fact that they exert their toxic
effects via different biochemical pathways. DCF inhibits
cyclooxygenases, OA inhibits protein-serine/threonine phos-
phatases and MZB causes oxidative stress and metal
accumulation.37,49,53
To the best of our knowledge, this is the first study
describing an in vitro electrochemical tool that utilizes the
voltammetric monitoring of nonspecific esterase activity in
monolayer-2D and spheroid-3D cultures of intestinal cells for
viability and toxicity evaluation.
■ EXPERIMENTAL SECTION
Materials and Reagents. All materials and reagents were
supplied as reported in the Supporting Information (SI).
Cell Culture. HIEC-6 cells (continuous human small intestine
epithelial cell line/ATCC CRL-3266), provided by LGC Standards
(Teddington, UK), were cultured in OptiMEM Reduced Serum
Medium, supplemented with 4% FBS, 10 mM GlutaMAX, 10 ng/mL
EGF, 100 units/mL penicillin, and 100 μg/mL streptomycin, under
standard cell culture conditions (5% CO2, 95% humidity, 37 °C).
Cells were maintained routinely in 75 cm2 cell culture flasks, media
were replenished every other day, and cells were subcloned through
trypsinization (0.25% trypsin, 0.02% EDTA) upon 80−90%
confluency. Cell adhesion and monolayer formation were routinely
visualized by phase contrast microscopy (Figure 1 A), while cell
numbers were determined with the use of a Neubauer chamber.
Generation of Spheroids. Multicellular spheroids were gen-
erated using the low attachment surface method according to the
protocol described by Phung et al.44 Briefly, after subcloning, cells
were counted and diluted to suspensions of 5 × 104 cells per milliliter
of medium. A volume of 200 μL of this cell suspension (for 10,000
cells per spheroid per microwell, Figure 1B) was added to each well of
U-shaped, 96-well polystyrene plates that had been previously coated
with poly-HEMA (5 mg/mL) to facilitate low attachment. Spheroid
formation was initiated by centrifugation of the plates at 1000g for 10
min. The plates were then incubated for 48 h under standard cell
culture conditions (5% CO2, 95% humidity, and 37 °C), which
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produced ∼400-μm-diameter spheroids (Figure 1C−E). This size
(∼400 μm) was preferred because spheroids are known to develop a
necrotic core around 500 μm (diameter),45 which could compromise
the toxicity studies. Phase-contrast imaging was routinely employed to
visualize cell aggregation and spheroid formation.
MTT Assay. Cell viability was assayed with respect to cellular
metabolic activity by the MTT reduction assay according to the
protocol described by Mosmann46 with minor changes as described in
the SI.
CFDA-AM Assay. Cell viability was additionally assayed with
respect to intracellular esterase activity by the CFDA-AM (5-
carboxyfluorescein diacetate acetomethyl ester) assay based on the
protocol by Ganassin et al.47 as described in the SI.
Xenobiotic Exposure. For 2D in vitro exposure, cells (passages 5
to 10) were transferred on clear 96-well plates for MTT viability
assays (colorimetric) and onto black 96-well plates for CFDA-AM
assays (fluorometric). The cells were allowed to attach themselves for
1 day before xenobiotic exposure (24 h, Opti-MEM Reduced Serum
Medium, 5% CO2, 95% humidity, 37 °C). For 3D in vitro exposure,
spheroids were transferred onto clear 96-well plates for MTT viability
assays and black 96-well plates for CFDA-AM assays. Stock
xenobiotics solutions were prepared by dissolving technical grade
substances in DMSO. Exposure media were prepared in Opti-MEM
Reduced Serum Medium and added to the plates reaching a final
DMSO concentration of 0.05%, which also served as the vehicle
control solution.
SPE Fabrication. The SPE stepwise fabrication is shown in Figure
1F. A DEK 248 screen-printing system (semiautomatic screen printer,
DEK International, Weymouth, Dorset, UK) was used to fabricate the
disposable SPEs. Carbon-ink tracks (3 tracks, 30 mm × 2 mm)
(Figure 1F) were screen printed on a Melinex 339 polyester sheet
(200 μm thickness), obtaining 140 screen-printed electrodes per A4
sheet. The electrode prints were allowed to air-dry at room
temperature overnight before the application of an insulation layer
(Figure 1F); consisting of a clear polyester layer (Melinex O, 100 μm)
bonded through 3 M chemical adhesive film (20 mm × 8 mm)
custom designed using CorelDraw graphics suite X5 software
(COREL OEM product) and laser machined using a 30 W CO2
laser cutter (Epilog Zing − Model 10000, USA). The Epilog Model
10000 system is a class 3R laser product (IEC 60825-1) and complies
with 21 CFR 1040.10 and 1040.11 FDA regulations. Subsequently,
Ag/AgCl paste, which served as the pseudo reference electrode, was
spotted (2.8 mm2) onto the middle electrode (Figure 1F) using a
glass capillary tube followed by drying at 60 °C for 2 h. Finally, the
electrode prints spotted with Ag/AgCl were covered with insulation
layer which defined the three-electrode configuration cavity and
electrical contacts.
Electrochemical Measurements. Cyclic voltammetry (CV)
experiments were performed using the computer-controlled potentio-
stat CHI 660C (CH Instruments Inc., Austin, TX, USA). Prior to
running each electrochemical experiment, an SPE was connected to
the potentiostat through a serial port interface and 20 μL of sample or
1-naphthol standards was transferred onto an SPE covering the three
electrode cavity (Figure 1F, illustration 4). Sodium phosphate buffer
solution (0.1 M, pH 6.5) was employed as supporting electrolyte. CVs
were recorded at a scan rate of 100 mV s−1 (vs Ag/AgCl), in the
potential range of −0.20 V to +0.55 V, for one cycle. Signal
acquisition was realized using CH Instruments software (CH
Instruments Inc.). All experiments were carried out at ambient
temperature of about 25 °C.
Electrochemical Cell Viability Assay Setup. The experimental
setup for electrochemical cell viability measurement is shown in
Figure 2. Cells at 80−90% confluence or spheroids of ∼400 μm
diameter were treated with the selected xenobiotics for 24 h. At the
end of the exposure period, media were removed and cells/spheroids
were gently washed with PBS followed by incubation with 5 mM 1-
naphthyl acetate in 0.1 M sodium phosphate buffer (pH: 6.5, 0.05%
Triton X-100 for monolayer cultures and 0.1% Triton X-100 for
spheroids) for 2 h. At the end of substrate incubation, 20 μL were
transferred onto an SPE and CVs were recorded as described above.
Statistical Analysis. Unless stated otherwise, all data were
collected from at least three independent experiments. Results are
expressed as the mean ± SD. Differences between means were tested
for statistical significance using a one-way analysis of variance
(ANOVA), followed by Dunnett’s post hoc test. All statistical
analyses were carried out with the SPSS Statistics v 20 (IBM Corp.,
Armonk, NY, USA) except dose response sigmoidal fitting, which was
Figure 1. (A) HIEC-6 monolayer culture and (B−E) multicellular
spheroids under dark field, phase contrast, and differential
interference contrast microscopy; scale bar represents 100 μm. (F)
Fabrication steps of the screen-printed electrode. Carbon ink is
printed on a polyester substrate followed by spotting of Ag/AgCl ink
and finished with an insulating layer.
Figure 2. Schematic representation of the 2D and 3D sensing principle for cell viability through electrochemical detection of 1-naphthol generated
by the nonspecific esterases of viable cells using disposable screen-printed sensors.
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performed with GraphPad Prism 7.04 (GraphPad Software, San
Diego, California, USA). The level of probability for statistical
significance was established at p ≤ 0.05 for all analyses.
■ RESULTS AND DISCUSSION
Principle of the Proposed Viability Electrochemical
Biosensor. Herein, we present a strategy for electrochemically
assaying the viability of intestinal 2D and 3D cell cultures.
Figure 2 illustrates the entire experimental setup of the
proposed assay, which utilizes a screen printed electrochemical
sensor for measuring the enzymatic hydrolysis of 1-naphthyl
acetate to 1-naphthol by nonspecific esterases of viable cells.
Substrate and Product Electrochemistry and Stability
Investigations. The electrochemical characterization of 1-
naphthol (1-NpOH) was carried out by cyclic voltammetry in
the potential range between −0.20 V and +0.55 V at scan rate
of 100 mVs−1 (vs Ag/AgCl) in sodium phosphate buffer
solution (0.1 M, pH 6.5). Figure 3A shows typical CV curves
of solutions containing successively increasing concentrations
of 1-NpOH (0−100 μM). The carbon SPE showed no obvious
electrochemical response in blank solution (0 μM), while in
the case of 1-NpOH, an oxidation process that starts at ca. +
0.25 V with a single anodic wave reaching a peak potential (Ep)
at around +0.35 V, was observed. The onset potential for the
analyte (1-NpOH) oxidation peak shifts slightly (cathodically,
from +0.25 V to +0.22 V) with increasing concentration of
analyte. This is likely due to the ease of diffusion of the analyte
to the interface of the electrode at the higher analyte
concentration. During the reverse scan, no cathodic waves or
reduction peaks were evident, suggesting that 1-NpOH
exhibits an irreversible electrochemical behavior at the carbon
SPEs. Overall, the CV curves of the various 1-NpOH solutions
reveal that the current response from the oxidation peaks
exhibit a strong positive linear correlation with 1-NpOH
concentration (R2 = 0.9966) in the studied range of 10 μM to
100 μM (Figure 3B). The limit of detection (LOD) was found
to be 2.20 μM calculated based on 3σ method as described.48
The substrate (1-naphthyl acetate, 1-NA) behavior was also
interrogated electrochemically before conducting the cytotox-
icity and viability experiments. No redox characteristics were
observed for the 1-NA at time zero (sodium phosphate buffer
solution, 0.1 M, pH 6.5) at room temperature (RT, 21 °C),
but over the time, a peak at around +0.38 V start appearing
which increases with the time (incubation period). The
magnitude of this current is of the order of ∼100 nA (2 h, RT,
n = 3) and found to be a function of time and temperature.
This indicates the chemical degradation or autohydrolysis of 1-
NA over the tested period. Under similar experimental
conditions but at 37 °C, a 4.4-fold signal increase was
observed compared to the response at RT, suggesting substrate
instability at higher temperatures. To overcome this degrada-
tion issue, all following substrate incubations were carried out
at RT.
Investigation of 1-Naphthol Production from Viable
Intestinal Cells. The generation of 1-naphthol by nonspecific
esterases of viable cells was investigated, both electrochemi-
cally and fluorometrically, using 1-naphthyl acetate (1-NA) as
a substrate. Once 1-NA is in the cytoplasm, nonspecific
esterases deacetylate the molecule to convert it to 1-naphthol.
For the electrochemical assessment of esterase activity, 1-
naphthol formation was monitored with cyclic voltammetry
using a potential window from −0.3 V to +0.5 V at a scan rate
of 100 mV s−1 (vs Ag/AgCl) in sodium phosphate buffer (0.1
M, pH 6.5). The CV curves of successively increasing cell
populations after incubation with 1-NA (Figure 3C) show that
the overall current responses (1-NpOH) were directly
proportional to the cell seeding densities as oxidation peak
current values increased with increasing cell numbers. A slight
anodic shift of the oxidation peak potential was observed
(∼+0.4 V) while monitoring cellular 1-naphthol generation
compared to the 1-NpOH standards (neat product, +0.35 V).
This is acceptable and likely due to residual protein content
from the tissue culture medium which may affect the sensor
surface and hence the performance. Printed carbon surfaces are
known to be susceptible to protein fouling due to surface
roughness and morphology features.49
A small background current (362.83 ± 8.97 nA) was also
observed in the case of cell-free culture medium (control
including substrate at room temperature, 2 h, Figure 3D),
which is higher than the previously observed substrate current
response of the order of ∼100 nA (2 h, room temperature),
suggesting additional hydrolysis of the substrate due to
possible residual activity of the cell culture medium. The 96
well plates used in this study comprise tissue culture-treated
flat bottoms to promote cell adhesion. The tissue culture
treatment process involves exposing the polystyrene to
vacuum-gas plasma to modify the hydrophobic plastic surface
into a more hydrophilic surface. The resulting surface carries a
net negative charge because of the oxygen-containing func-
tional groups such as −OH and −COOH. These groups aid
Figure 3. (A) Cyclic voltammograms of a series of 1-naphthol
concentrations in sodium phosphate buffer solution (0.1 M, pH 6.5)
at a scan rate of 100 mV s−1 (vs Ag/AgCl). (B) Relationship between
1-naphthol concentration (μM) and oxidation peak current (nA)
values for the data shown in A. (C) Cyclic voltammograms of
increasing cell populations and (D) their corresponding oxidation
peak values against cell numbers. (E) Fluorescence intensities at 1-
naphthol’s emission max wavelength (λem ∼ 460 nm) plotted against
cell numbers. (F) CFDA-AM fluorescence intensity (λem= 530 nm)
against cell numbers. Values are expressed as mean ± SD, one-way
ANOVA, Dunnett’s test, **p ≤ 0.01, ***p ≤ 0.001, vs control.
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the adhesion of proteins/enzymes from the fetal bovine serum
supplement of the cell culture medium. According to the
literature, fetal bovine serum contains esterase enzymes44,45
and could be responsible for the 1-naphthol detection on the
cell free samples. This response, however, can be considered
negligible, as it is significantly different compared to all the
studied cell populations at the 99.9% confidence level (one-
way ANOVA, Dunnett’s test, ***p ≤ 0.001 vs control, Figure
3D).
Considering 1-naphthol’s fluorescence properties, its cellular
generation was also investigated fluorometrically. As shown in
Figure 3E, the fluorescence intensities of successively
increasing cell populations, at the emission max of 1-naphthol
(λem ∼ 460 nm),50 after incubation with 1-NA, showed a
strong positive correlation with cell numbers, without any
statistically significant difference when comparing the control
(no cells) with the lowest cell population (5 × 103 cells, p =
0.48 > 0.05 vs control, Figure 3E), suggesting that the
electrochemical approach could be more sensitive for low cell
numbers. Further, nonspecific esterase of cells was also
evaluated using the CFDA-AM assay (Figure 3F). The
fluorogenic dye CFDA is a viability probe that measures cell-
membrane integrity through enzymatic activity. This mem-
brane permeable, nonpolar, nonfluorescent substance can be
converted by nonspecific esterases of living cells into a polar,
fluorescent dye, carboxyfluorescein (CF). The conversion to
Figure 4. Representative morphology of the 2D monolayers of intestinal cells at intermediate-dose and high-dose treatments of diclofenac,
mancozeb, and okadaic acid, along with untreated controls, respectively. Scale bar represents 100 μm.
Figure 5. Dose−response curves for 2D intestinal xenobiotic exposure on the inhibition of cell viability based on the MTT (A, D, G) and CFDA-
AM (B, E, H) assays and normalized sensor response (C, F, I) fitted by nonlinear regression.
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CF by the cells indicates the integrity of the cell membrane
(plasma membrane or cytoplasmic membrane), since only an
intact membrane can maintain the cytoplasmic milieu which is
needed to support esterase activity.51 When plotted against cell
numbers, CF fluorescence intensities showed a strong positive
correlation with cell numbers, without any statistically
significant difference between the control (no cells) with the
lowest cell population (5 × 103 cells, p = 0.28 > 0.05 vs
control, Figure 3F), suggesting that the electrochemical
approach could be more sensitive for low cell numbers.
Electrochemical Cytotoxicity Assessment and Viabil-
ity Analysis. After establishing a correlation between cell
number and electrochemical response, the nonsteroidal anti-
inflammatory drug diclofenac, the diarrheic shellfish poisoning
toxin okadaic acid, and the ethylene bisdithiocarbamate
fungicide mancozeb, all widely studied for their adverse effects
on the gastrointestinal tract, were selected as models to assess
the ability of the proposed assay to monitor intestinal cell
viability.
To study the effect of the above xenobiotics on the intestinal
viability (MTT, CFDA-AM) and sensor response (1-NpOH
electrochemical detection), cell monolayers and spheroids
were treated with different concentrations of each substance
for 24 h. MTT assay is one of the most widely used
cytotoxicity/cell proliferation assays; the yellow tetrazolium
salt MTT is reduced by mitochondrial dehydrogenases of
living cells to blue formazan crystals, giving an indirect measure
of cell metabolism. CFDA-AM, as discussed earlier, is also an
established viability/cytotoxicity probe. At the end of the
exposure period, the toxin-containing culture medium was
aspirated; cells or spheroids were gently washed with PBS and
subsequently incubated with MTT, CFDA-AM, and 1-NA for
4, 1, and 2 h, respectively. At the end of the incubation,
viability was assayed optically, fluorometrically, and micro-
scopically, while CVs were recorded as described previously.
Data from all three assays were plotted against applied doses
and fitted to sigmoidal curves as shown in Figure 5 and Figure
7, while morphology observations are presented in Figure 4
and Figure 6.
Xenobiotic exposure resulted in a dose-dependent decrease
in MTT absorbance, CFDA-AM fluorescence intensity,
electrochemical response, and morphology alterations for all
three tested substances in both 2D and 3D culture formats.
In the case of 2D culture format, maximal cytotoxic effects
were observed at concentrations over 2 mM for the DCF, 20
μM for MZB, and 500 nM for OA for all three assays.
Microscopy observations of the exposed monolayer cultures
showed clear signals of cytotoxicity with increasing concen-
trations of the xenobiotics. Treated cells suffered by
morphological modifications such as rounding up and
detaching from the substrate, cell aggregation, swell/shrink
perturbations, blebbing, or cell lysis (Figure 4).
Dose response sigmoidal curve fitting (Figure 5) for MTT
indicated median lethal concentrations (LC50) of 0.60−1.36
mM (95% CI) for DCF, 4.42−14.38 μM (95% CI) for MZB,
and 32.19−42.81 nM (95% CI) for OA, respectively. CFDA-
AM LC50 values ranged from 0.32 to 1.34 mM (95% CI) for
DCF, 3.39−11.88 μM (95% CI) for MZB, and 66.61−128.10
nM (95% CI) for OA, respectively. Finally, sensor IC50 values
(median inhibitory concentrations) were calculated at 1.19−
1.26 mM (95% CI) for DCF, 10.28−14.18 μM (95% CI) for
MZB, and 40.91−77.13 nM (95% CI) for OA, respectively. All
sensor IC50 values were found within the same concentration
range (95% CI) with the LC50 values of the conventional
viability assays (MTT and CFDA-AM) indicating that the
results of the proposed electrochemical assay are a strong
indication of cytotoxicity in monolayer cultures.
Similar to the 2D data obtained in this study, previous
studies on DCF cytotoxicity on monolayer cultures have
reported LC50 values of ∼0.68 mM for hepatoma cells,52 ∼0.5
mM for canine kidney cells,53 and 0.8 mM for human donor
hepatocytes.54 DCF toxicity data on intestinal cell lines are
scarce; however, studies on cytotoxicity of DCF in human
precision-cut intestinal slices report significant toxicity above
0.4 mM55 comparable with all three assays of the present
study. Literature data on MZB gastrointestinal cytotoxicity
report a 54% decreased survival rate of human gastric NSU-1
cells after 24 h exposure to 10 μM MZB, results also in concert
with the data of the present study. Other investigators have
reported MZB toxicity in transformed colon (large intestine)
cells with LC50 values ranging from 40 μΜ to 180 μΜ,43
results notably higher than our observed data. This disparity
could be attributed to the fact that colon cells have been
demonstrated to be more resistant to pesticide exposure when
compared to other cell types.56 Finally, OA exposure on
intestinal cells has been reported to result LC50 values of
Figure 6. Representative morphology of the 3D intestinal spheroids at intermediate-dose and high-dose treatments of diclofenac, mancozeb, and
okadaic acid, along with untreated controls, respectively. Images were recorded using an inverted microscope in integrated modulation contrast
(IMC) mode; scale bar represents 100 μm.
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16.59−82.75 nM (95% CI) for Caco-2 human colon cells,57 in
close range with the 95% CI results of all three assays of the
present study.
In the case of 3D culture format, spheroid toxicity was
observed morphologically under an inverted microscope in
integrated modulation contrast (IMC) mode. The spheroids
were generated using pellet culture on low attachment U-
shaped microplates, which along with the hanging drop
method58,59 allow for more precise control of spheroid size
and high-throughput formats. Other methods for spheroid
generation include the spinner culture method, the rotating
wall vessel, and the electric/magnetic force, which have high
yields but the produced spheroids often vary in both size and
shape.60
As shown in Figure 6, control spheroids are characterized by
rounded, smooth surfaces without clearly defined individual
cells, while treated ones exhibit a rippled, rough surface with
clearly defined individual cells, phenotypic changes typical of
toxicity.61 The overall morphology of the untreated spheroids
shows compact formations, contrary to the disintegrated,
“loosened up” structures of the treated ones.
When comparing the viability results of the 2D cell culture
format (Figure 5) with the 3D format (Figure 7), we observed
a shift of the LC50 and IC50 values to higher concentration
ranges (95% CI) for all three xenobiotics. Dose response
sigmoidal curve fitting of the MTT (Figure 7A,D,G) indicated
LC50s of 0.68−4.12 mM (95% CI) for DCF, 12.21−15.98 μM
(95% CI) for MZB, and 129.50−314.10 nM (95% CI) for OA,
respectively. Sigmoidal curve fitting of the sensor 3D results
indicated IC50 values of 1.02−4.78 mM (95% CI) for DCF,
11.26−15.16 μM (95% CI) for MZB, and 162.09−179.67 nM
(95% CI) for OA, respectively. CFDA-AM was unable to
resolve differences in any compound (Figure 7B,E,H),
suggesting that the CFDA-AM microplate method is
insufficient in assaying 3D spheroids compared to 2D
monolayers, potentially due to depth-dependent light scatter-
ing obstruction, that attenuates fluorescence excitation and
emission intensity61 in the case of formations like spheroids.
This limitation, however, does not seem to affect the optical
MTT assay, possibly because of the final solvent lysis step
(DMSO) that is employed before the absorbance readings.
Similarly, the addition of the detergent Triton X-100, in the
case of the proposed electrochemical sensor, allowed the
permeabilization of the cells and the release of the end-product
from the cytosol. Triton X-100 is known to effectively
permeabilize mammalian cells for cellular enzyme activity
measurements,62 without damaging cellular structure. All
sensor 3D IC50 values (Figure 7C,F,I) were found within the
same concentration range (95% CI) with the LC50 values of
the conventional MTT assays indicating that the proposed
electrochemical assay can reflect cytotoxicity in 3D culture
format.
The results of both the conventional viability and sensor
assays employed in the present work show that, unlike their 2D
counterparts, 3D cultures of HIEC-6 were less susceptible to
lower concentrations of the toxicants. Those results were
expected and consistent with numerous literature reports on
3D toxicological studies,63−65 as 3D cultures bear an additional
dimension of cell to cell and cell to extracellular matrix contact
which improves the viability of their systems.66 A known
limitation of using 2D culture systems for toxicological studies
is that they could lead to overestimation of toxicity as a
Figure 7. Dose−response curves for 3D intestinal xenobiotic exposure on the inhibition of cell viability based on the MTT (A, D, G) and CFDA-
AM (B, E, H) assays and normalized sensor response (C, F, I) fitted by nonlinear regression.
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consequence of the absence of 3D cell organization. When
subjected to xenobiotic exposure, 3D spheroids are reported to
have the ability to impair the diffusion of the toxicant to their
core, as the cells on their outer layers provide a natural barrier.
Additionally, spheroid formation is known to enhance drug
efflux activities,67 which affects their drug resistance, mimicking
in vivo conditions. The proposed sensor was able to detect the
enhanced xenobiotic resistance of cells in 3D architecture as
indicated by the increased 3D IC50 values compared with the
2D ones. Similar results on 3D over 2D toxicity resistance have
been reported in other bioassay development studies on mouse
embryonic fibroblasts,68 human hepatoma cells,65 human
neuroblastoma, and glioblastoma cells.69
■ CONCLUSION
Sensors that assess cellular cytotoxic responses have been
exploited for a broad range of applications. The use of
mammalian cells in biosensors can provide responses relevant
to human physiology. Of the various toxicity sensors that have
been proposed, however, there are few studies adopting
electrochemical sensors to evaluate both 2D and 3D cell
culture formats. In this study, we developed an electrochemical
assay for cell viability/toxicity measurements based on the
enzymatic activity of nonspecific esterase of healthy, intact
cells. Based on this enzyme based biosensor, it is convenient to
measure the viability of both 2D and 3D cell culture formats
and provide more dynamic data for drug/toxicity screening.
The proposed biosensor showed a high consistency with the
conventional cell viability assays applied in this work and
relevant literature. All sensor IC50 values were found within the
same concentration range (95% CI) with the LC50 values of
the conventional viability assays indicating that the results of
the proposed electrochemical assay are a good indication for
cytotoxicity in both 2D and 3D culture formats. The resulting
assay offers a simple and robust endpoint cytotoxicity
screening in 2D and 3D architecture. Further work will focus
on investigating additional cell types and 3D architectures,
sensor surface modifying/improving techniques, substrate
molecules and on minimizing substrate incubation time.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acssen-
sors.8b01490.




*E-mail: Baljit.Singh@ittdublin.ie. Tel: +353 1 404 2033. Fax:






The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
Dr. Baljit Singh thanks and acknowledges Enterprise Ireland
and European Regional Development Fund 2014-2020
Programme (ERDF, European Union) for provision of
financial support. MiCRA Biodiagnostics is funded under the
Enterprise Ireland Technology Gateway Programme (Grant
Number: TG20171013).
■ REFERENCES
(1) Barlow, S. M.; Greig, J. B.; Bridges, J. W.; Carere, A.; Carpy, A. J.
M.; Galli, C. L.; Kleiner, J.; Knudsen, I.; Koeẗer, H. B. W. M.; Levy, L.
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